MTRNR2L10: A Potential Drug Target and Biomarker (G100463488)

Target Name: MTRNR2L10

NCBI ID: G100463488

MTRNR2L10

MTRNR2L10: A Potential Drug Target and Biomarker

MTRNR2L10, a gene located on chromosome 6, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. The MTRNR2L10 gene encodes for a non-coding RNA molecule that has been shown to play a critical role in regulating the expression of genes involved in cell growth, differentiation, and survival.

MTRNR2L10 has been shown to promote the growth and survival of various cancer cell lines, including breast, ovarian, and colorectal cancer. This suggests that MTRNR2L10 may be a useful target for cancer treatment. In addition, MTRNR2L10 has also been shown to contribute to the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

The MTRNR2L10 gene has also been associated with various metabolic disorders, including obesity, type 2 diabetes, and polycystic ovary syndrome (PCOS). These associations suggest that MTRNR2L10 may be a potential biomarker for monitoring the effectiveness of obesity and other metabolic disorders.

In addition to its potential drug target and biomarker properties, MTRNR2L10 also has important cellular and molecular functions. The MTRNR2L10 RNA molecule has been shown to act as a negative regulator of the NF-kappa-B signaling pathway, which is involved in various cellular processes, including inflammation, cell survival, and metabolism.

The MTRNR2L10 gene has also been shown to play a role in regulating the expression of genes involved in cell adhesion, migration, and the association with cancer stem cells. These functions are important for the development and progression of cancer, and may be potential targets for cancer treatment.

In conclusion, MTRNR2L10 is a gene that has potential as a drug target and biomarker for various diseases. Further research is needed to fully understand the functions of MTRNR2L10 and its potential as a drug.

Protein Name: MT-RNR2 Like 10 (pseudogene)

Functions: Plays a role as a neuroprotective and antiapoptotic factor

The "MTRNR2L10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTRNR2L10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets